RBN013209

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

RBN013209 is an orally active small molecule inhibitor of CD38 with an IC50 of 0.01 to 0.1 μM for human CD38. RBN013209 prevents the conversion of extracellular NAD+ to ADPR or cADPR in tumor cells and PBMCs. RBN013209 can be used in the study of tumor. In addition, RBN013209 enables CAR-T cells to maintain the naive state and central memory state, and decreases the expression of cell activation markers and exhaustion-related inhibitory receptors.

For research use only. We do not sell to patients.

  • Purity: 98.63%
  • CAS No.: 2597933-17-8
  • Formula: C19H24N6O3
  • Molecular Weight:384.43
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) RBN013209

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00